BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hassan M, Cargill T, Harriss E, Asciak R, Mercer RM, Bedawi EO, McCracken DJ, Psallidas I, Corcoran JP, Rahman NM. The microbiology of pleural infection in adults: a systematic review. Eur Respir J 2019;54:1900542. [PMID: 31248959 DOI: 10.1183/13993003.00542-2019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Gozdas HT. Is ceftriaxone a suitable option for the empirical treatment of postoperative pleural empyema? J Chemother 2021;:1. [PMID: 34435539 DOI: 10.1080/1120009X.2021.1963619] [Reference Citation Analysis]
2 Kanellakis NI, Wrightson JM, Gerry S, Ilott N, Corcoran JP, Bedawi EO, Asciak R, Nezhentsev A, Sundaralingam A, Hallifax RJ, Economides GM, Bland LR, Daly E, Yao X, Maskell NA, Miller RF, Crook DW, Hinks TSC, Dong T, Psallidas I, Rahman NM. The bacteriology of pleural infection (TORPIDS): an exploratory metagenomics analysis through next generation sequencing. The Lancet Microbe 2022. [DOI: 10.1016/s2666-5247(21)00327-x] [Reference Citation Analysis]
3 Maitre T, Ok V, Calin R, Lassel L, Canestri A, Denis M, Hamidi M, Tavolaro S, Verdet C, Parrot A, Cadranel J, Pialoux G. Pyogenic lung abscess in an infectious disease unit: a 20-year retrospective study. Ther Adv Respir Dis 2021;15:17534666211003012. [PMID: 34098822 DOI: 10.1177/17534666211003012] [Reference Citation Analysis]
4 Hassan M, Daneshvar C, Corcoran JP. Pleural Infection—a Growing Problem in the Elderly. Curr Geri Rep 2020;9:47-53. [DOI: 10.1007/s13670-020-00320-y] [Reference Citation Analysis]
5 Hassan M, Corcoran JP, Daneshvar C. Factors associated with variations in the rate of referrals and microbiology of pleural infection. Expert Rev Respir Med 2020;14:1165-71. [PMID: 32736488 DOI: 10.1080/17476348.2020.1804874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Sundaralingam A, Banka R, Rahman NM. Management of Pleural Infection. Pulm Ther 2021;7:59-74. [PMID: 33296057 DOI: 10.1007/s41030-020-00140-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Cargill TN, Hassan M, Corcoran JP, Harriss E, Asciak R, Mercer RM, McCracken DJ, Bedawi EO, Rahman NM. A systematic review of comorbidities and outcomes of adult patients with pleural infection. Eur Respir J 2019;54:1900541. [PMID: 31391221 DOI: 10.1183/13993003.00541-2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Hjertman J, Bläckberg J, Ljungquist O. 16S rRNA is a valuable tool in finding bacterial aetiology of community-acquired pleural empyema-a population-based observational study in South Sweden. Infect Dis (Lond) 2021;:1-7. [PMID: 34606399 DOI: 10.1080/23744235.2021.1985165] [Reference Citation Analysis]
9 Iliopoulou M, Skouras V, Psaroudaki Z, Makarona M, Vogiatzakis E, Tsorlini E, Katsifa E, Spyratos D, Siopi D, Kotsiou O, Xitsas S, Martsoukou M, Sigala I, Kalomenidis I. Bacteriology, antibiotic resistance and risk stratification of patients with culture-positive, community-acquired pleural infection. J Thorac Dis 2021;13:521-32. [PMID: 33717525 DOI: 10.21037/jtd-20-2786] [Reference Citation Analysis]
10 Bedawi EO, Guinde J, Rahman NM, Astoul P. Advances in pleural infection and malignancy. Eur Respir Rev 2021;30:200002. [PMID: 33650525 DOI: 10.1183/16000617.0002-2020] [Reference Citation Analysis]
11 Porcel JM, Ferreiro L, Rumi L, Espino-Paisán E, Civit C, Pardina M, Schoenenberger-Arnaiz JA, Valdés L, Bielsa S. Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial. Pleura Peritoneum 2020;5:20190027. [PMID: 32934974 DOI: 10.1515/pp-2019-0027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chen Z, Cheng H, Cai Z, Wei Q, Li J, Liang J, Zhang W, Yu Z, Liu D, Liu L, Zhang Z, Wang K, Yang L. Identification of Microbiome Etiology Associated With Drug Resistance in Pleural Empyema. Front Cell Infect Microbiol 2021;11:637018. [PMID: 33796482 DOI: 10.3389/fcimb.2021.637018] [Reference Citation Analysis]
13 Sundaralingam A, Bedawi EO, Rahman NM. Diagnostics in Pleural Disease. Diagnostics (Basel) 2020;10:E1046. [PMID: 33291748 DOI: 10.3390/diagnostics10121046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Addala DN, Bedawi EO, Rahman NM. Parapneumonic Effusion and Empyema. Clin Chest Med 2021;42:637-47. [PMID: 34774171 DOI: 10.1016/j.ccm.2021.08.001] [Reference Citation Analysis]
15 Bobbio A, Bouam S, Frenkiel J, Zarca K, Fournel L, Canny E, Icard P, Porcher R, Alifano M. Epidemiology and prognostic factors of pleural empyema. Thorax 2021:thoraxjnl-2020-215267. [PMID: 33785584 DOI: 10.1136/thoraxjnl-2020-215267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Hassan M, Patel S, Sadaka AS, Bedawi EO, Corcoran JP, Porcel JM. Recent Insights into the Management of Pleural Infection. Int J Gen Med 2021;14:3415-29. [PMID: 34290522 DOI: 10.2147/IJGM.S292705] [Reference Citation Analysis]
17 Zhang L, Li J, Liang J, Zhang Z, Wei Q, Wang K. The effect of Cyclic-di-GMP on biofilm formation by Pseudomonas aeruginosa in a novel empyema model. Ann Transl Med 2020;8:1146. [PMID: 33240995 DOI: 10.21037/atm-20-6022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Nwagboso CI, Ekeng BE, Etiuma AU, Ochang EA, Eze JN, Echieh CP. Microbiological profile and antibiotic resistance pattern of empyema thoracis in Calabar, Nigeria. Trop Doct 2021;51:523-6. [PMID: 34459297 DOI: 10.1177/00494755211032844] [Reference Citation Analysis]